Working… Menu

Arthralgia of the Temporomandibular Joint. Pain Relief Following One Intra-articular Injection of Methylprednisolone

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01995019
Recruitment Status : Completed
First Posted : November 26, 2013
Last Update Posted : May 19, 2017
Information provided by (Responsible Party):
Uppsala University

Brief Summary:

The hypothesis is that a single dose intra-articular injection of corticosteroids are effective in relieving temporomandibular arthralgia pain.

The purpose of the study is therefore to evaluate the effect of a single dose intra-articular methylprednisolone vs. placebo in a month perspective on subjects with unilateral arthralgia of the TMJ.

Condition or disease Intervention/treatment Phase
Arthralgia TMJ Drug: Methylprednisolone Drug: Physiologic saline Phase 4

Detailed Description:

This is a randomized blinded multicenter controlled study on 64 subjects (18 years or older) with the diagnosis of unilateral arthralgia of the TMJ.

The subject visit the clinic at three occasions; one enrollment visit, one baseline treatment visit and one evaluation visit one month after baseline.

One week after baseline a follow-up telephone call is made with the purpose to track adverse events.

Pain questionaries are completed morning, lunch and dinnertime during three days before treatment, five days after treatment and three days proceeding the evaluation visit.

The study ís planned to commence 10th December 2013 and last patient out 15th January 2015.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 56 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: PhaseIV Study of Intra-articular Methylprednisolone in TMJ Arthralgia
Actual Study Start Date : December 10, 2013
Actual Primary Completion Date : March 15, 2017
Actual Study Completion Date : March 15, 2017

Arm Intervention/treatment
Placebo Comparator: Physiologic saline
Sodium chloride 9 mg/ml liquid for parental use
Drug: Methylprednisolone
1 ml single dose Intra-articular Depo-Medrol 40 mg/ml
Other Name: Depo-Medrol 40 mg/ml

Experimental: Methylprednisolone
Depo-Medrol 40 mg/ml, single dose, injection, intra-articular
Drug: Physiologic saline
1 ml intra-articular placebo
Other Name: Sham substance

Primary Outcome Measures :
  1. VAS pain score change at maximal mouth opening [ Time Frame: 4 weeks ]
    100 mm analog Visual Analog Scale with endpoints "No pain" and "Worst pain imaginable" The intra-individual change of the VAS pain score between baseline and end of study

Secondary Outcome Measures :
  1. VAS pain score change at jaw rest [ Time Frame: 4 weeks ]
    100 mm analog Visual Analog Scale with endpoints "No pain" and "Worst pain imaginable" The intra-individual change of the VAS pain score between baseline and end of study

  2. Instrument measures [ Time Frame: 4 weeks ]

  3. Adverse events [ Time Frame: 4 weeks ]

    Spontaneously reported by the subject or observed by the study staff from the baseline visit until the evaluation visit.

    Reported by the subject in response to open questioning at visits/phone calls from the baseline visit until the evaluation visit "Have you had any health problems since your last visit/contact?"

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • age 18 or above
  • the diagnosis arthralgia in one TMJ
  • understands Swedish both verbally and in written
  • signed informed concent

Exclusion Criteria:

  • TMJ sounds in terms of clicking (crepitation allowed))
  • polyarthritis/connective tissue disease
  • bilateral TMJ arthralgia
  • fibromyalgia or other generalized pain
  • ongoing infection
  • ongoing dental treatment
  • intra-articular corticosteroid injection of a TMJ the past 6 months
  • previous surgery of the affected TMJ
  • complex psychiatric/psychologic status
  • institutionalized living including prisoners
  • staff at the investigational clinic
  • hypersensitive to local anesthetics
  • hypersensitive to methylprednisolone
  • hemophilia
  • methemoglobinemia
  • nursing
  • compromized health status according to the judgment of the investigator
  • concommitant use of the drugs cyclosporine, erythromycin, pentobarbital, itraconazole, ketoconazole, Rifampicin, Acetylsalicylic acid, Oral anticoagulant
  • mentally retarded

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01995019

Layout table for location information
Orofacial pain unit, Malar Hospital Eskilstuna
Eskilstuna, Södermanland, Sweden, 631 88
Dental specialist clinic Kaniken
Uppsala, Uppland, Sweden, 75148
Specialist clinic Stomatognathic physiology
Goteborg, VastraGotaland, Sweden, 40233
Specialist center
Uddevalla, VastraGotaland, Sweden, 45180
Orofacial pain unit, Västmanland Hospital Västerås
Västerås, Västmanland, Sweden, 72185
Orofacial pain unit Eastman Institute
Stockholm, Sweden, 113 24
Orofacial pain unit, Dental Specialist Education Center
Örebro, Sweden, 70111
Sponsors and Collaborators
Uppsala University
Layout table for investigator information
Principal Investigator: Göran Isacsson, DDS Orofacial pain unit, Västmanland Hospital Västerås
Layout table for additonal information
Responsible Party: Uppsala University Identifier: NCT01995019    
Other Study ID Numbers: Artralgia1
2013-003365-34 ( EudraCT Number )
First Posted: November 26, 2013    Key Record Dates
Last Update Posted: May 19, 2017
Last Verified: May 2017
Keywords provided by Uppsala University:
Temporomandibular joint
Additional relevant MeSH terms:
Layout table for MeSH terms
Joint Diseases
Musculoskeletal Diseases
Neurologic Manifestations
Methylprednisolone Acetate
Methylprednisolone Hemisuccinate
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate
Anti-Inflammatory Agents
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Gastrointestinal Agents
Hormones, Hormone Substitutes, and Hormone Antagonists
Neuroprotective Agents
Protective Agents
Antineoplastic Agents, Hormonal
Antineoplastic Agents